Old Web
English
Sign In
Acemap
>
authorDetail
>
J.Gerry. Everlof
J.Gerry. Everlof
Bristol-Myers Squibb
Organic chemistry
Chemistry
Dosage form
Enthalpy change of solution
Mole
3
Papers
70
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
An Amide-Based Sulfenamide Prodrug of Gamma Secretase Inhibitor BMS–708163 Delivers Parent Drug from an Oral Conventional Solid Dosage Form in Male Beagle Dog
2020
Bioorganic & Medicinal Chemistry Letters
Victor R. Guarino
Richard E. Olson
J.Gerry. Everlof
Nenghui Wang
Ivar M. McDonald
Roy Haskell
Wendy Clarke
Kimberley A. Lentz
Show All
Source
Cite
Save
Citations (2)
Both 5-arylidene-2-thioxodihydropyrimidine-4,6(1H,5H)-diones and 3-thioxo-2,3-dihydro-1H-imidazo[1,5-a]indol-1-ones are light-Dependent tumor necrosis factor-α antagonists
2003
Bioorganic & Medicinal Chemistry Letters
Matthew E. Voss
Percy H. Carter
Andrew J. Tebben
Peggy A. Scherle
Gregory D. Brown
Lorin A. Thompson
Meizhong Xu
Yvonne C. Lo
Gengjie Yang
Rui-Qin Liu
Paul Strzemienski
J.Gerry. Everlof
James M. Trzaskos
Carl P. Decicco
Show All
Source
Cite
Save
Citations (54)
Polymorphism of Roxifiban
2002
Journal of Pharmaceutical Sciences
Michael B. Maurin
Rodney Vickery
Shelley R. Rabel
Susan M. Rowe
J.Gerry. Everlof
Gregory A. Nemeth
G. Creston Campbell
C.M. Foris
Show All
Source
Cite
Save
Citations (14)
1